Log in
Enquire now
‌

US Patent 9347044 Reprogramming T cells and hematopoietic cells

Patent 9347044 was granted and assigned to Cellular Dynamics International on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Cellular Dynamics International
Cellular Dynamics International
0
Current Assignee
Cellular Dynamics International
Cellular Dynamics International
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93470440
Patent Inventor Names
Matthew Brown0
Randy Learish0
Amanda Mack0
Deepika Rajesh0
Elizabeth Rondon Dominguez0
Emile Nuwaysir0
Date of Patent
May 24, 2016
0
Patent Application Number
142589710
Date Filed
April 22, 2014
0
Patent Citations Received
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
Patent Primary Examiner
‌
Valarie Bertoglio
0
Patent abstract

Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9347044 Reprogramming T cells and hematopoietic cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.